Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors as of March 31, 2021

Portfolio Holdings for Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors holds 31 positions in its portfolio as reported in the March 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Springworks Therapeutics (SWTX) 24.3 $429M 5.8M 73.57
Atea Pharmaceuticals (AVIR) 19.6 $347M 5.6M 61.75
Arcutis Biotherapeutics (ARQT) 6.5 $115M 4.0M 28.93
Dynavax Technologies (DVAX) 6.1 $107M 11M 9.83
Annexon (ANNX) 5.1 $90M 3.2M 27.84
Pharvaris N V (PHVS) 5.0 $89M 3.2M 27.98
Dicerna Pharmaceuticals 4.5 $79M 3.1M 25.57
C4 Therapeutics Com Stk (CCCC) 3.4 $61M 1.6M 36.99
Mersana Therapeutics (MRSN) 3.4 $60M 3.7M 16.18
Solid Biosciences 2.5 $44M 7.9M 5.53
Syros Pharmaceuticals 2.5 $43M 5.8M 7.48
Nurix Therapeutics (NRIX) 2.3 $40M 1.3M 31.09
Constellation Pharmceticls I 1.9 $33M 1.4M 23.39
Aptinyx 1.5 $27M 8.9M 3.00
Savara (SVRA) 1.4 $24M 12M 2.08
Marinus Pharmaceuticals (MRNS) 1.3 $22M 1.4M 15.48
Aeglea Biotherapeutics 1.2 $21M 2.7M 7.92
Kymera Therapeutics (KYMR) 1.1 $19M 480k 38.86
X4 Pharmaceuticals (XFOR) 1.0 $18M 2.1M 8.61
Crinetics Pharmaceuticals In (CRNX) 0.9 $16M 1.1M 15.28
Bluebird Bio (BLUE) 0.9 $16M 538k 30.15
Arya Sciences Acquisition Corp Iii Com Cl A 0.8 $14M 1.0M 13.78
Therapeutics Acquisition Corp Com Cl A 0.6 $11M 1.0M 10.51
Research Alliance Corp Ii Com Cl A 0.6 $10M 1.0M 10.25
Arya Sciences Acquisition Corp Iv Cl A (ARYD) 0.4 $7.3M 700k 10.47
Bctg Acquisition Corp 0.3 $5.6M 500k 11.12
Bcls Acquisition Corp Com Cl A 0.3 $5.2M 488k 10.57
Omega Alpha Spac Cl A 0.2 $4.0M 400k 9.90
Frazier Lifesciences Acquisition Corp Unit 12/09/2025 0.2 $3.0M 300k 10.16
Jiya Acquisition Corp Com Cl A 0.2 $3.0M 300k 9.84
Helix Acquisition Corp Com Cl A 0.1 $2.6M 250k 10.20